China's market will be largely driven by continued market reforms, prominence of policy-driven thematic opportunities, diversification...

Most Notable: regeneron v mylan: regeneron does not seek injunctive relief but new patents filed moderna v alnylam: rejection of...

With the top being Pfizer, Merck, Bristol-Myers Squib, JnJ.